Traditional Chinese medicine decoction for treating aplastic anemia

Abstract

The invention discloses a traditional Chinese medicine decoction for treating aplastic anemia. The traditional Chinese medicine decoction comprises the following raw materials in parts by weight: 11-14 parts of gordon euryale seed, 2-4 parts of glossy privet fruit, 1-2 parts of Chinese dodder seed, 3.5-4.5 parts of human placenta, 3-4 parts of panax pseudoginseng, 2-4 parts of obscured homalomenarhizome, 3-5 parts of danshen root, 8-10 parts of barbary wolfberry fruit, 3-4 parts of turtle shell, 2-4 parts of Chinese caterpillar fungus, 1-3 parts of white mulberry root-bark, 4-6 parts of desertliving cistanche, 3-5 parts of Eastern bracken fern rhizome, 2-4 parts of dendrobium, 4-6 parts of curled dock root, 5-7 parts of fineleaf schizonepeta herb, 2-4 parts of cherry blossom, 1-3 parts of India canna flower, 2-4 parts of gleditsia sinensis lam and 1-3 parts of lotus rhizome node. The traditional Chinese medicine decoction for treating aplastic anemia disclosed by the invention is high in curative effect, has the effects of nourishing yin and suppressing yang, tonifying the kidney and controlling nocturnal emission, softening hardness and dissipating stagnation, removing fever and eliminating steam, cooling the blood and removing blood stasis, astringing for stopping bleeding, harmonizing and nourishing the blood and the like, is prepared from pure traditional Chinese medicines, is rapid in medicament action, can be used for rapidly removing clinical symptoms, and is small in side or toxic effect, short in treatment course, small in pain and low in cost.

Description

technical field [0001] The invention relates to a traditional Chinese medicine decoction for treating aplastic anemia, which belongs to the field of traditional Chinese medicines. Background technique [0002] Aplastic anemia, referred to as aplastic anemia, is a group of comprehensive diseases caused by the damage of bone marrow hematopoietic stem cells and hematopoietic microenvironment caused by chemical, physical, biological factors and unknown reasons; the clinical manifestation is pancytopenia And the resulting anemia, bleeding and infection; aplastic anemia is generally divided into acute aplastic anemia and chronic aplastic anemia, mainly due to pancytopenia and corresponding clinical symptoms, such as leukopenia, the patient is susceptible to infection, fever, etc.; Palpitations, fatigue, dizziness, etc. are common in red blood cells; bleeding is seen in thrombocytopenia; commonly used anti-anemia drugs are ineffective, and the treatment costs are high, and recurren...

AI Technical Summary

Problems solved by technology

[0002] Aplastic anemia, referred to as aplastic anemia, is a group of comprehensive diseases caused by the damage of bone marrow hematopoietic stem cells and hematopoietic microenvironment caused by chemical, physical, biological factors and unknown reasons; the clinical manifestation is pancytopenia And the resulting anemia, bleeding and infection; aplastic anemia is generally divided into acute aplastic anemia and chronic aplastic anemia, mainly due to pancytopenia and corresponding clinical symptoms, such as leukopenia, the patient is susceptible to infection, fever, etc.; Palpitations, fatigue, dizziness, etc. are common in red blood cells; bleeding is seen in thrombocytopenia; commonly used anti-anemia drugs are ineffective, and the treatment costs are high, and recurrence is easy